LILLY-B4Z-MC-LYAC

Study Sponsor: Lilly

Study Title

A Phase 3 Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety
Comparison of Fixed-Dose Ranges (mg/kg/day) of Tomoxetine with Placebo in Child and Adolescent Outpatients with ADHD, Aged 8 to 18 Years

Medicine or Vaccine (generic name)

Atomoxetine

Sponsor Identification Number

B4Z-MC-LYAC

Trial Registry Identification Number(#'s)

Not available

Medical Condition

Attention Deficit Hyperactivity Disorder

Phase

Phase 3

Link to study details on the Lilly Clinical Study Register

Link to study details on ClinicalTrials.gov (if available)

Not available

Link to study details on EudraCT (if available)

Not available

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

A link to Clinicaltrials.gov and a NCT ID number are not available for this study because the study was conducted before regulatory requirements to register studies.

Date Added to this Site

November 2014